BNGOW (Bionano Genomics) Total Equity: $37.46 Mil (As of Mar. 2026)

What is Bionano Genomics Total Equity?

Bionano Genomics BNGOW 64 Total Equity is $37.46 Mil as of Mar. 2026. GuruFocus rates BNGOW with a GF Score™ of 64/100. The stock has 3 warning signs investors should review.

Bionano Genomics's total equity for the quarter that ended in Mar. 2026 was $37.46 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Bionano Genomics Total Equity Related Terms

Bionano Genomics Total Equity Historical Data

* Premium members only.

The historical data trend for Bionano Genomics's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionano Genomics Total Equity Chart

Bionano Genomics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Equity

Get a 7-Day Free Trial

337.12

249.40

96.16

35.38

44.42

Bionano Genomics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Equity	Get a 7-Day Free Trial															48.19	45.37	49.80	44.42	37.46

64GF Score

Bionano Genomics Inc BNGOW

Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Bionano Genomics Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Bionano Genomics's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2025 )	-	Total Liabilities(Q: Dec. 2025 )
	=	73.584	-	29.16
	=	44.42

Bionano Genomics's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity	=	Total Assets(Q: Mar. 2026 )	-	Total Liabilities(Q: Mar. 2026 )
	=	64.804	-	27.341
	=	37.46

Frequently Asked Questions Learn more about Total Equity →

What does a Total Equity of $37.46 Mil mean?

Bionano Genomics (BNGOW) has a Total Equity of $37.46 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Bionano Genomics and its competitors.

Is Bionano Genomics' Total Equity too high?

Bionano Genomics' current Total Equity is $37.46 Mil. Overall, Bionano Genomics has a GF Score™ of 64/100, reflecting its overall financial health beyond just this single metric.

How does Bionano Genomics' Total Equity compare to UEEC and CUPR?

Bionano Genomics' Total Equity of $37.46 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Equity for a Medical Devices & Instruments company?

A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Equity mean?

A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Bionano Genomics and its competitors. Bionano Genomics's current Total Equity is $37.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Bionano Genomics stock overvalued right now?

Bionano Genomics (BNGOW) has a current Total Equity of $37.46 Mil. The current Total Equity is $37.46 Mil. Bionano Genomics' overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Equity calculated?

Total Equity is calculated from a company's financial statements. For Bionano Genomics (BNGOW), the current Total Equity is $37.46 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionano Genomics Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies UEEC CUPR FEMY ZJYL MHUAF CBSC RVP LUCY NXGL RSCF ISRG XPAR:EL TSE:7741 BDX XSWX:ALC MDLN RMD WST XSWX:STMN TSE:4543

Other Exchanges BNGO:USA BNGO:Mexico

Address 9540 Towne Centre Drive, Suite 100, San Diego, CA, USA, 92121

Website https://www.bionano.com

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

64GF Score

Get the complete analysis for BNGOW

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View BNGOW Analysis

See Total Equity data for all stocks →